NCT00782041 Patients Who Have Failed First Line Treatment for Locally Advanced and/or Metastatic Cervical Cancer Status TERMINATED Phase PHASE2
NCT00778154 Study of Bone Histomorphometry, Microarchitecture, and Matrix Structure in Patients Receiving Alendronate or Risedronate Status COMPLETED Phase N/A
NCT00777699 Safety Study of XL765 (SAR245409) in Combination With Erlotinib in Adults With Solid Tumors Status COMPLETED Phase PHASE1
NCT00777348 To Assess the Protective Effect of the Fixed Drug Combination of Disodium Cromoglycate Plus Reproterol Status COMPLETED Phase PHASE2
NCT00774878 Study of AVE1642 (IGF-1R/CD221) in Combination With Fulvestrant (Faslodex®) in Postmenopausal Patients With Advanced Hormono-dependent Breast Cancer Status TERMINATED Phase PHASE2
NCT00774319 TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck Cancer Status UNKNOWN Phase PHASE2
NCT00772954 Phase I Randomized, Placebo-Controlled, Double-Blind, Dose Ranging Study, Safety, Tolerability and Immunogenicity Status TERMINATED Phase PHASE1
NCT00772928 Study of the Effect of Pneumococcal Conjugate Vaccine (PCV) on Immunogenicity of Pentacel™ Status COMPLETED Phase PHASE3
NCT00772863 Efficacy and Safety of Subsequent Cisplatin and Docetaxel in Ovarian Cancer Status COMPLETED Phase PHASE2
NCT00772681 Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx Carcinoma Status COMPLETED Phase PHASE4
NCT00772525 Single Oral Doses Study of Nerispirdine on Visual Function in Patients With Multiple Sclerosis Status COMPLETED Phase PHASE2
NCT00772395 Can Risedronate Prevent Periprosthetic Bone Loss After Total Hip Arthroplasty Status COMPLETED Phase PHASE4
NCT00766688 Evaluation of Safety and Efficacy of AVE5530 as add-on to Ongoing High Doses of Statins in Patients With Primary Severe Hypercholesterolemia Status TERMINATED Phase PHASE3
NCT00763815 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Pioglitazone Status COMPLETED Phase PHASE3
NCT00763451 GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Metformin Status COMPLETED Phase PHASE3
NCT00761670 Efficacy Study on Cognitive Functions in Schizophrenic Patients Status COMPLETED Phase PHASE4
NCT00761241 Borderline Resectable Pancreatic Cancer: Gemcitabine/Docetaxel and Oxaliplatin Based Chemo/RT Status COMPLETED Phase PHASE2